AAP
AGL icon

Arax Advisory Partners’s Agilon Health AGL Stock Holding History

Arax Advisory Partners’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.17K Buy
274
+272
+13,600% +$4.4K ﹤0.01% 3088
2025
Q4 		$36 Sell
2
-50
-96% -$970 ﹤0.01% 3970
2025
Q3 		$1.34K Buy
+52
New +$1.96K ﹤0.01% 3194
2024
Q4 		– Sell
-5
Closed -$496 – 2423
2024
Q3 		$496 Hold
5
– – ﹤0.01% 2405
2024
Q2 		$825 Buy
+5
New +$712 ﹤0.01% 2227

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return